ZA964139B - Polymorphs of Lesopitron dihydrochloride and its hydrated forms, preparation processes and compositions containing it. - Google Patents

Polymorphs of Lesopitron dihydrochloride and its hydrated forms, preparation processes and compositions containing it.

Info

Publication number
ZA964139B
ZA964139B ZA9604139A ZA964139A ZA964139B ZA 964139 B ZA964139 B ZA 964139B ZA 9604139 A ZA9604139 A ZA 9604139A ZA 964139 A ZA964139 A ZA 964139A ZA 964139 B ZA964139 B ZA 964139B
Authority
ZA
South Africa
Prior art keywords
polymorphs
compositions containing
preparation processes
hydrated forms
lesopitron dihydrochloride
Prior art date
Application number
ZA9604139A
Other languages
English (en)
Inventor
Pilar Lupon Roses
Jaime Tomas Navarro
Salvador Puig Torres
Jordi Frigola Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of ZA964139B publication Critical patent/ZA964139B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9604139A 1995-05-31 1996-05-23 Polymorphs of Lesopitron dihydrochloride and its hydrated forms, preparation processes and compositions containing it. ZA964139B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09501086A ES2099031B1 (es) 1995-05-31 1995-05-31 Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen.

Publications (1)

Publication Number Publication Date
ZA964139B true ZA964139B (en) 1997-02-06

Family

ID=8290585

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9604139A ZA964139B (en) 1995-05-31 1996-05-23 Polymorphs of Lesopitron dihydrochloride and its hydrated forms, preparation processes and compositions containing it.

Country Status (29)

Country Link
US (1) US5872125A (es)
EP (1) EP0771798A1 (es)
JP (1) JPH10503532A (es)
CN (1) CN1076020C (es)
AR (1) AR003952A1 (es)
AU (1) AU699210B2 (es)
BG (1) BG62966B1 (es)
CA (1) CA2196425A1 (es)
CO (1) CO4700461A1 (es)
CZ (1) CZ24797A3 (es)
EE (1) EE9700067A (es)
ES (1) ES2099031B1 (es)
GE (1) GEP20002241B (es)
HU (1) HUP9700284A3 (es)
IL (1) IL118494A0 (es)
IN (1) IN186820B (es)
IS (1) IS4420A (es)
MA (1) MA23883A1 (es)
MX (1) MX9700792A (es)
NO (1) NO310073B1 (es)
NZ (1) NZ308110A (es)
PL (1) PL318280A1 (es)
RU (1) RU2178789C2 (es)
SK (1) SK12697A3 (es)
TR (1) TR199600455A2 (es)
UY (1) UY24241A1 (es)
WO (1) WO1996038439A1 (es)
YU (1) YU32396A (es)
ZA (1) ZA964139B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2654621B1 (fr) * 1989-11-22 1994-09-23 Esteve Labor Dr Inhibition du syndrome d'abstinence.
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2671972B1 (fr) * 1991-01-25 1995-03-03 Esteve Labor Dr Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .

Also Published As

Publication number Publication date
CA2196425A1 (en) 1996-12-05
HUP9700284A3 (en) 1998-01-28
MX9700792A (es) 1997-05-31
NO970392L (no) 1997-04-01
NZ308110A (en) 1997-08-22
SK12697A3 (en) 1997-07-09
ES2099031A1 (es) 1997-05-01
JPH10503532A (ja) 1998-03-31
ES2099031B1 (es) 1997-12-01
CN1158128A (zh) 1997-08-27
US5872125A (en) 1999-02-16
RU2178789C2 (ru) 2002-01-27
AU699210B2 (en) 1998-11-26
CN1076020C (zh) 2001-12-12
EP0771798A1 (en) 1997-05-07
IL118494A0 (en) 1996-09-12
UY24241A1 (es) 1996-06-14
PL318280A1 (en) 1997-06-09
BG101176A (en) 1997-08-29
IN186820B (es) 2001-11-17
CZ24797A3 (en) 1997-05-14
HU9700284D0 (en) 1997-04-28
AU5765096A (en) 1996-12-18
NO970392D0 (no) 1997-01-29
WO1996038439A1 (es) 1996-12-05
AR003952A1 (es) 1998-09-30
MA23883A1 (fr) 1996-12-31
YU32396A (sh) 1999-07-28
CO4700461A1 (es) 1998-12-29
TR199600455A2 (tr) 1996-12-21
GEP20002241B (en) 2000-09-25
EE9700067A (et) 1997-10-15
IS4420A (is) 1997-01-29
NO310073B1 (no) 2001-05-14
BG62966B1 (bg) 2000-12-29
HUP9700284A2 (en) 1997-11-28

Similar Documents

Publication Publication Date Title
EP0811595A4 (en) HYDROCHALCONE DERIVATIVES, COSMETIC COMPOSITIONS CONTAINING THEM AND PROCESSES FOR PREPARING SUCH DERIVATIVES OR COMPOSITIONS
EP1037639A4 (en) HETEROARYL-SUBSTITUTED IMIDAZOLE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES
HK1011856A1 (en) Cement formulation.
ZA961867B (en) Underarm compositions.
HK1031869A1 (en) 1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds.
IL124086A (en) Process for the preparation of 1,1,1,3,3-pentafluoropropane
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
IL117656A0 (en) Pharmaceutical compositions for the treatment of travellers diarrhea
PL340372A1 (en) Novel 3,6x-hemiketals of 9a-azalydes class
ZA965922B (en) Preparation of N-substituted 3-hydroxypyrazoles.
GB9820753D0 (en) Synthesis of 1,1,1,3,3-Pentafluoropropane
ZA968249B (en) Underarm compositions.
ZA961868B (en) Antiperspirant aerosol composition.
IL117655A0 (en) Pharmaceutical compositions for the treatment of travellers diarrhea
ZA979151B (en) Pyrazolinones for treating impaired potency.
HUP0001878A3 (en) (r)-3-(n,n-dicyclobutyl-amino)-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxamide hydrogen tartrate, process for its preparation and pharmatceutical compositions of the same
EP0852503A4 (en) AGENTS FOR THE TREATMENT OF DIARRHÖ, THEIR USE AND PRODUCTION
IL113057A0 (en) Compositions for the treatment of dandruff
ZA979643B (en) Heterocyclic compounds, compositions and uses.
ZA979642B (en) Heterocyclic compounds, compositions and uses.
ZA964139B (en) Polymorphs of Lesopitron dihydrochloride and its hydrated forms, preparation processes and compositions containing it.
ZA968252B (en) Underarm compositions.
ZA979644B (en) Heterocyclic compounds, compositions and uses.
EP0682034A3 (en) Process for the preparation of cyanoalkylorganooxysilanes from cyanoalkylchlorosilanes.
GB9814269D0 (en) 9a-Aza-3-ketolides, compositions containing such compounds and methods of treatment